ELB 139
Alternative Names: ELB-139Latest Information Update: 23 Aug 2007
Price :
$50 *
At a glance
- Originator elbion NV
- Class Anxiolytics
- Mechanism of Action GABA A receptor agonists; Serotonin modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders
Most Recent Events
- 05 Dec 2006 4AZA Bioscience has merged with elbion to form elbion NV
- 12 Dec 2005 Data presented at the 35th Annual Meeting of the Society for Neuroscience (SfN-2005) have been added to the adverse events, and Anxiety disorders and Psychotic disorders pharmacodynamics sections ,,,
- 24 Nov 2005 Data presented at the 18th Annual Congress of the European College of Neuropsychopharmacology (ECNP-2005) have been added to the Anxiety disorders and Epilepsy and movement disorders pharmacodynamics sections